# CardioDx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cardiodx

- Industry: Biotechnology
- Headquarters: Redwood City, US
- Total disclosed funding: $210M
- Latest round: Series F (Oct 12, 2012)
- Investors on record: 14

## About

Established in 2004 and based in California, US, CardioDx, Inc. operates as a developer of genomic tests to individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias and heart failure.

## Funding rounds

- Series F, Oct 12, 2012, $29M — Pappas Capital
- Series F, Aug 16, 2012, $29M — GE Capital, Equity, Kleiner Perkins, Mohr Davidow Ventures, Temasek Holdings, Intel Capital, Pappas Capital, DAG Ventures, Artiman Ventures, Longitude Capital, JP Morgan Asset Management, TPG Biotech, Asset Management Ventures, Acadia Woods Partners, Bright Capital
- Series E, Jun 17, 2011, $69M — GE Capital, Equity, Kleiner Perkins, Mohr Davidow Ventures, Intel Capital, Pappas Capital, DAG Ventures, Artiman Ventures, Longitude Capital, JP Morgan Asset Management, TPG Biotech, Asset Management Ventures, Acadia Woods Partners, Bright Capital
- Series E, Feb 17, 2011, $2M — Kleiner Perkins, Mohr Davidow Ventures, Pappas Capital, Longitude Capital
- Series D, May 6, 2010, $35M — GE Capital, Equity, Kleiner Perkins, Mohr Davidow Ventures, Intel Capital, Pappas Capital, DAG Ventures, TPG Biotech, Asset Management Ventures
- Series C, Oct 1, 2008, $28M — Kleiner Perkins, Mohr Davidow Ventures, Intel Capital, TPG Biotech
- Series B, Jul 21, 2006, $19M — Kleiner Perkins, Mohr Davidow Ventures, TPG Biotech

## Investors

- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series B, Series C, Series D, Series E, Series F
- Mohr Davidow Ventures (https://capitalatlas.ai/funds/mohr-davidow-ventures) — Series B, Series C, Series D, Series E, Series F
- TPG Biotech (https://capitalatlas.ai/funds/tpg-biotech) — Series B, Series C, Series D, Series E, Series F
- Intel Capital (https://capitalatlas.ai/funds/intel-capital) — Series C, Series D, Series E, Series F
- GE Capital, Equity (https://capitalatlas.ai/funds/ge-capital-equity) — Series D, Series E, Series F
- Pappas Capital (https://capitalatlas.ai/funds/pappas-capital) — Series D, Series E, Series F
- DAG Ventures (https://capitalatlas.ai/funds/dag-ventures) — Series D, Series E, Series F
- Asset Management Ventures (https://capitalatlas.ai/funds/asset-management-ventures) — Series D, Series E, Series F
- Longitude Capital (https://capitalatlas.ai/funds/longitude-capital) — Series E, Series F
- Artiman Ventures (https://capitalatlas.ai/funds/artiman-ventures) — Series E, Series F
- JP Morgan Asset Management (https://capitalatlas.ai/funds/jp-morgan-asset-management) — Series E, Series F
- Acadia Woods Partners (https://capitalatlas.ai/funds/acadia-woods-partners) — Series E, Series F
- Bright Capital — Series E, Series F
- Temasek Holdings — Series F